INSYS Therapeutics Files to Withdraw IPO Plans Published: Sep 09, 2008 NEW YORK, Sept 8 (Reuters) - U.S. biopharmaceutical company Insys Therapeutics Inc filed to withdraw its plans for an $86.3 million initial public offering, citing market conditions. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news